Cargando…

Octreotide Infusion for the Treatment of Congenital Chylothorax

Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobeisy, Sumayyah Ahmed Nezar, Alkhotani, Abdulaziz, Barzanji, Mohammed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673913/
https://www.ncbi.nlm.nih.gov/pubmed/33224547
http://dx.doi.org/10.1155/2020/8890860
_version_ 1783611413015560192
author Kobeisy, Sumayyah Ahmed Nezar
Alkhotani, Abdulaziz
Barzanji, Mohammed M.
author_facet Kobeisy, Sumayyah Ahmed Nezar
Alkhotani, Abdulaziz
Barzanji, Mohammed M.
author_sort Kobeisy, Sumayyah Ahmed Nezar
collection PubMed
description Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion.
format Online
Article
Text
id pubmed-7673913
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76739132020-11-19 Octreotide Infusion for the Treatment of Congenital Chylothorax Kobeisy, Sumayyah Ahmed Nezar Alkhotani, Abdulaziz Barzanji, Mohammed M. Case Rep Pediatr Case Report Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion. Hindawi 2020-11-11 /pmc/articles/PMC7673913/ /pubmed/33224547 http://dx.doi.org/10.1155/2020/8890860 Text en Copyright © 2020 Sumayyah Ahmed Nezar Kobeisy et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kobeisy, Sumayyah Ahmed Nezar
Alkhotani, Abdulaziz
Barzanji, Mohammed M.
Octreotide Infusion for the Treatment of Congenital Chylothorax
title Octreotide Infusion for the Treatment of Congenital Chylothorax
title_full Octreotide Infusion for the Treatment of Congenital Chylothorax
title_fullStr Octreotide Infusion for the Treatment of Congenital Chylothorax
title_full_unstemmed Octreotide Infusion for the Treatment of Congenital Chylothorax
title_short Octreotide Infusion for the Treatment of Congenital Chylothorax
title_sort octreotide infusion for the treatment of congenital chylothorax
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673913/
https://www.ncbi.nlm.nih.gov/pubmed/33224547
http://dx.doi.org/10.1155/2020/8890860
work_keys_str_mv AT kobeisysumayyahahmednezar octreotideinfusionforthetreatmentofcongenitalchylothorax
AT alkhotaniabdulaziz octreotideinfusionforthetreatmentofcongenitalchylothorax
AT barzanjimohammedm octreotideinfusionforthetreatmentofcongenitalchylothorax